BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19367089)

  • 21. Blueprint for a deliberative public forum on biobanking policy: were theoretical principles achievable in practice?
    Molster C; Maxwell S; Youngs L; Kyne G; Hope F; Dawkins H; O'Leary P
    Health Expect; 2013 Jun; 16(2):211-24. PubMed ID: 21645188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community recommendations on biobank governance: Results from a deliberative community engagement in California.
    Dry SM; Garrett SB; Koenig BA; Brown AF; Burgess MM; Hult JR; Longstaff H; Wilcox ES; Madrigal Contreras SK; Martinez A; Boyd EA; Dohan D
    PLoS One; 2017; 12(2):e0172582. PubMed ID: 28235046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influencing health policy through public deliberation: Lessons learned from two decades of Citizens'/community juries.
    Degeling C; Rychetnik L; Street J; Thomas R; Carter SM
    Soc Sci Med; 2017 Apr; 179():166-171. PubMed ID: 28285232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Access arrangements' for biobanks: a fine line between facilitating and hindering collaboration.
    Fortin S; Pathmasiri S; Grintuch R; Deschênes M
    Public Health Genomics; 2011; 14(2):104-14. PubMed ID: 20689244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ASTUTE Health study protocol: deliberative stakeholder engagements to inform implementation approaches to healthcare disinvestment.
    Watt AM; Hiller JE; Braunack-Mayer AJ; Moss JR; Buchan H; Wale J; Riitano DE; Hodgetts K; Street JM; Elshaug AG;
    Implement Sci; 2012 Oct; 7():101. PubMed ID: 23088222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The public and public health organizations: issues for community engagement in public health.
    Scutchfield FD; Hall L; Ireson CL
    Health Policy; 2006 Jun; 77(1):76-85. PubMed ID: 16139924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deliberations about deliberative methods: issues in the design and evaluation of public participation processes.
    Abelson J; Forest PG; Eyles J; Smith P; Martin E; Gauvin FP
    Soc Sci Med; 2003 Jul; 57(2):239-51. PubMed ID: 12765705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving drug policy: The potential of broader democratic participation.
    Ritter A; Lancaster K; Diprose R
    Int J Drug Policy; 2018 May; 55():1-7. PubMed ID: 29428297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethnocultural community leaders' views and perceptions on biobanks and population specific genomic research: a qualitative research study.
    Godard B; Ozdemir V; Fortin M; Egalité N
    Public Underst Sci; 2010 Jul; 19(4):469-85. PubMed ID: 20977184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From 'trust us' to participatory governance: Deliberative publics and science policy.
    Burgess MM
    Public Underst Sci; 2014 Jan; 23(1):48-52. PubMed ID: 24434712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community engagement for big epidemiology: deliberative democracy as a tool.
    McWhirter RE; Critchley CR; Nicol D; Chalmers D; Whitton T; Otlowski M; Burgess MM; Dickinson JL
    J Pers Med; 2014 Nov; 4(4):459-74. PubMed ID: 25563457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biobank governance: trends and perspectives.
    Gottweis H; Zatloukal K
    Pathobiology; 2007; 74(4):206-11. PubMed ID: 17709961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Power to the people: a wiki-governance model for biobanks.
    Dove ES; Joly Y; Knoppers BM
    Genome Biol; 2012 May; 13(5):158. PubMed ID: 22647613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulating Gene Editing in the Wild: Building Regulatory Capacity to Incorporate Deliberative Democracy.
    Maschke KJ; Gusmano MK
    Hastings Cent Rep; 2021 Nov; 51 Suppl 2():S42-S47. PubMed ID: 34905250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing a deliberative democracy method with citizens of African ancestry to weigh pros and cons of targeted screening for hereditary breast and ovarian cancer risk.
    Guan Y; Pathak S; Ballard D; Veluswamy JK; McCullough LE; McBride CM; Gornick MC
    Front Public Health; 2022; 10():984926. PubMed ID: 36424974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biobanking from the patient perspective.
    Mitchell D; Geissler J; Parry-Jones A; Keulen H; Schmitt DC; Vavassori R; Matharoo-Ball B
    Res Involv Engagem; 2015; 1():4. PubMed ID: 29062493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Science and deliberation].
    Ravazzi S
    Epidemiol Prev; 2008; 32(6):319-24. PubMed ID: 19353967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Between consensus and contestation.
    Weale A
    J Health Organ Manag; 2016 Aug; 30(5):786-95. PubMed ID: 27468774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring the contribution of tumor biobanks to research in oncology: surrogate indicators and bibliographic output.
    Hofman V; Ilie M; Long E; Washetine K; Chabannon C; Figarella-Branger D; Clément B; Mabile L; Cambon-Thomsen A; Boucher P; Dagher G; Hewitt R; Parodi B; Hofman P
    Biopreserv Biobank; 2013 Aug; 11(4):235-44. PubMed ID: 24845591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychogeriatric care: building rural community capacity.
    Morrow MH; Hemingway D; Grant J; Jamer B
    Rural Remote Health; 2012; 12():1971. PubMed ID: 22650617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.